Old Mutual Customised Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Old Mutual Customised Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$2.11M	Sell	12,426 -600	-5%	-$93K	0.21%	120
2018 Q1	$2.12M	Hold	13,026	–	–	0.22%	121
2017 Q4	$1.95M	Buy	13,026 +5,500	+73%	+$814K	0.2%	126
2017 Q3	$1.14M	Hold	7,526	–	–	0.16%	153
2017 Q2	$970K	Hold	7,526	–	–	0.14%	173
2017 Q1	$823K	Buy	7,526 +826	+12%	+$72.7K	0.13%	203
2016 Q4	$494K	Buy	6,700 +2,700	+68%	+$220K	0.09%	275
2016 Q3	$349K	Buy	4,000 +600	+18%	+$56.7K	0.1%	238
2016 Q2	$292K	Sell	3,400 -600	-15%	-$51.8K	0.07%	321
2016 Q1	$318K	Buy	4,000 +100	+3%	+$9.04K	0.08%	300
2015 Q4	$491K	Hold	3,900	–	–	0.12%	200
2015 Q3	$406K	Buy	3,900 +600	+18%	+$77.1K	0.11%	222
2015 Q2	$407K	Buy	3,300 +400	+14%	+$50.4K	0.1%	264
2015 Q1	$342K	Buy	2,900 +2,500	+625%	+$300K	0.08%	292
2014 Q4	$48K	Buy	400 +200	+100%	+$22.5K	0.01%	646
2014 Q3	$22K	Sell	200 -800	-80%	-$76.2K	0.01%	662
2014 Q2	$95K	Hold	1,000	–	–	0.02%	612
2014 Q1	$71K	Buy	1,000 +300	+43%	+$23.8K	0.02%	650
2013 Q4	$52K	Hold	700	–	–	0.01%	694
2013 Q3	$53K	Hold	700	–	–	0.02%	676
2013 Q2	$56K	Buy	+700	New	+$51.5K	0.02%	684

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Old Mutual Customised Solutions's VRTX Position: Q2 2018 in Review

Old Mutual Customised Solutions reduced its Vertex Pharmaceuticals (VRTX) stake by 4.6% in Q2 2018, selling an estimated $93K and leaving 12,426 shares worth $2.11M. The position accounts for 0.21% of the portfolio, ranked #120.

Old Mutual Customised Solutions first reported a position in VRTX in Q2 2013 and has held it in 21 quarters since. The position peaked at $2.12M in Q1 2018. 690 funds tracked by Wall St. Rank hold VRTX as of Q2 2018.

Old Mutual Customised Solutions held 12,426 shares of Vertex Pharmaceuticals worth $2.11M as of Q2 2018.
Old Mutual Customised Solutions sold 600 Vertex Pharmaceuticals shares in Q2 2018, an estimated $93K.
Vertex Pharmaceuticals made up 0.21% of Old Mutual Customised Solutions's portfolio in Q2 2018, its #120 holding.
Old Mutual Customised Solutions first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 21 quarters since.
Old Mutual Customised Solutions's Vertex Pharmaceuticals position peaked at $2.12M in Q1 2018.
690 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2018.

Based on Old Mutual Customised Solutions's 13F filing for Q2 2018, filed 14 Aug 2018.